EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[Mucinous gastric carcinomas (MGC)]

1) Introductory case

2) Definition of MGCs

3) Two types of MGCs - differentiated (= low grade) vs undifferentiated (= high grade)

4) Depth of invasion is difficult to guess in MGCs

5) MGCs can mimick a submucosal tumor

6) Difficult to make diagnosis using forceps biopsy

7) More cases

8) FAQs

9) References


1. Introductory case

On the greater curvature side of the proximal antrum, there was a 4 cm-sized, round, dome-like, elevated mass with central shallow ulceration and spontaneous bleeding. Although the ulceration was not deep, the endoscopist's impression was (1) Borrmann type 2 advanced gastric cancer and (2) lymphoma (less likely). However, the final pathology after surgical resection was mucinous adenocarcinoma with deep submucosal (SM3) invasion. Therefore, it is a case of AGC-like EGC.


À§¾ÏÀ¸·Î ÀÇ·Ú¹Þ¾Ò½À´Ï´Ù. ³»½Ã°æÀº Fujifilm À̾ú½À´Ï´Ù.

Á¶Á÷°Ë»ç¿¡¼­ ¹ú½á mucin poolÀÌ ³Ð°Ô º¸¿´½À´Ï´Ù.

¼ö¼úÀ» ½ÃÇàÇÏ¿´½À´Ï´Ù.


2. Definition of mucinous gastric carcinoma (MGC)

MGC is defined by the World Health Organization (WHO) as a gastric adenocarcinoma with a substantial amount of extracellular mucin (50% of tumor volume) within tumors.


3. Two types of MGCs

Mucinous gastric adenocarcinoma can be devided into two groups -- differentiated (= low grade) vs undifferentiated (= high grade).

Two types of mucinous gastric adenocarcinoma were discussed in a recent Korean study (Lee, 2012). The conclusion of the study was that compared with patients with poorly differentiated adenocarcinoma, the overall survival of patients with undifferentiated mucinous adenocarcinoma was statistically significantly worse and those with signet ring cell carcinoma had a better prognosis. See one paragraph in the introduction section.

"According to the World Health Organization (WHO) classification, the four predominant histological types of gastric adenocarcinoma are tubular adenocarcinoma, papillary adenocarcinoma, mucinous adenocarcinoma (MAC) and signet ring cell carcinoma (SRC). Unlike tubular adenocarcinoma, which is graded as well-, moderately- or poorly-differentiated according to the degree of glandular formation, papillary adenocarcinoma is usually classified as well-differentiated, and SRC as poorly-differentiated. The Japanese classification system categorizes gastric adenocarcinomas into two groups: differentiated and undifferentiated. The differentiated group consists of well-differentiated, moderately-differentiated and papillary adenocarcinoma. The undifferentiated group consists of poorly differentiated adenocarcinoma (PDAC) and SRC. Interestingly, MAC can be regarded as either a differentiated or undifferentiated type depending on the predominant components. In the same context, Nakamura categorized all gastric cancer as either differentiated or undifferentiated."

According to a report from Japan (Kunisaki, 2006), undifferentiated mucinous gastric adenocarcinoma has following characteristics.

  1. Higher frequency of metastasis to lymph nodes and lymphatic and venous invasion
  2. Anatomical extent of metastatic spread to lymph nodes was more widespread
  3. Advanced tumor stage
  4. More frequent peritoneal metastasis at the initial diagnosis was more frequent
  5. Poor curability


4. Depth of invasion is difficult to guess in mucinous gastric carcinomas

Endoscopic differentiation between EGC and AGC is not easy. According to the experience at our institution (Shin 2010), 9.3 % of pathologically confirmed AGCs were initially considered as EGC by endoscopy. Similarly, 8.1 % of pathologically confirmed EGCs were initially considered as AGC by endoscopy. EUS (endoscopic ultrasonography) may help evaluate the depth of invasion, but routine use of EUS before surgery or ESD is not supported by quality evidences.

WHO definition of mucinous adenocarcinoma is "an adenocarcinoma in which a substantial amount of extracellular mucin (more than 50% of the tumor) is retained within the tumor". Japanese definition is "an adenocarcinoma characterized by a substantial number of mucous lakes due to mucin pooling in the tumor stroma."

Mucinous adenocarcinoma is one of important types of AGC-like EGC. There is an abundant mucin pool between tumor cells, so the cancer lesion commonly looks like an elevated mass lesion. Some cases with AGC-like EGC (mucinous adenocarcinoma) can be found in the literature.

One interesting point of mucinous adenocarcinom is that it is also a common type of EGC-like AGC. So the endoscopic evaluation of invasion depth is very difficult for mucinous adenocarcinoma.

Mucinous adenocarcinom (PM invasion)

Mucinous adenocarcinom (PM invasion)


5. Mucinous gastric carcinomas can mimick a SMT (submucosal tumor)

Mucinous adenocarcinoma can mimick submucosal tumor. Followings are two typical cases from a recent case report (Yu. J Korean Surg Soc 2013;84:118).


6. Difficult to make diagnosis using forceps biopsy.

Other challenging aspect of mucinous adenocarcinoma is that the pre-treatment pathologic diagnosis is impossible in most cases. The pretreatment biopsy is usually poorly differentiated adenocarcinoma or signet ring cell carcinoma. It is because the existence of mucin pool is difficult to see in tiny biopsy specimens. Followings are some more examples of mucinous adenocarcinoma.

Mucinous adenocarcinoma´Â Á¶Á÷°Ë»ç¿¡¼­ ¾ÏÀÌ ³ª¿ÀÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù. Mucin pool¿¡ ¾Ï¼¼Æ÷°¡ µÕµÕ ¶° ÀÖ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î...


7. More cases of mucinous gastric carcinomas

Mucinous adenocarcinoma (M, muscularis mucosa)

Mucinous adenocarcinoma (SM1)

Mucinous adenocarcinoma (SM2) presented as intractable gastric ulcer

Mucinous adenocarcinoma (SM3)

Mucinous adenocarcinoma (SM3)

Mucinous adenocarcinoma (Proper muscle, LN positive)

Mucinous adenocarcinoma (Subserosa)

Mucinous adenocarcinoma (Subserosa, LN positive)

Mucinous adenocarcinoma (Subserosa, LN positive)

Mucinous adenocarcinoma (Subserosa)

Mucinous adenocarcinoma (penetrates serosa, LN positive)

Mucinous adenocarcinoma (penetrates serosa, LN positive)

Mucinous adenocarcinoma (penetrates serosa, LN positive). º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀÇ Á¶Á÷ÇüÀº ´ëºÎºÐ poorly differentiated ȤÀº signet ring cell carcinomaÀÔ´Ï´Ù. °£È¤ mucinous adenocarcinomaµµ º¸¸¸ 4ÇüÀÇ ¸ð½ÀÀ» º¸ÀÔ´Ï´Ù. º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀε¥ CT¿¡¼­ À¯³­È÷ gastric wall thickeningÀÌ ÇöÀúÇÏ¿´½À´Ï´Ù. ¼ö¼ú ÈÄ ¾Æ·¡¿Í °°Àº °á°ú¸¦ ¾ò¾ú½À´Ï´Ù. Å©±â°¡ ¹«·Á 20cm À̾ú½À´Ï´Ù. Mucinous adenocarcinoma¿´±â ¶§¹®¿¡ mucin lake°¡ À§º®À» µÎ²®°Ô ¸¸µç °æ¿ì¿´´Ù°í »ý°¢µË´Ï´Ù.
Histologic type : mucinous adenocarcinoma
- Histologic type by Lauren : diffuse
- Size : 20x14.5x2.2 cm
- Depth of invasion : extension to subserosa (pT2b)
- Resection margin: free from carcinoma: safety margin: proximal, 4.3 cm; distal, 0.2 cm
- Lymph node metastasis: metastasis to 5 out of 49 regional lymph nodes (pN1)
- Lymphatic invasion : present
- Venous invasion : present (extramural)
- Perineural invasion : not identified

Mucinous adenocarcinoma (direct extension to adjacent structure (mesocolon), LN positive)

Stomach, subtotal gastrectomy:
Advanced gastric carcinoma
1. Location : [1] lower third, [2] duodenum, Center at antrum and lesser curvature, anterior wall
2. Gross type : Borrmann type 2
3. Histologic type : mucinous adenocarcinoma (mucinous carcinoma portion: 100%)
4. Histologic type by Lauren : diffuse
5. Size : 4.5x4 cm
6. Depth of invasion : subserosal connective tissue (pT3)
7. Resection margin: free from carcinoma; safety margin: proximal 4.5 cm, distal 1.5 cm
8. Lymph node metastasis : metastasis to 9 out of 38 regional lymph nodes (pN3a), (perinodal extension: present) (9/38: "3", 2/8; "4", 0/4; "5", 3/4; "6", 2/5; "7", 0/5; "9", 1/1; "8a", 0/8; "11p", 0/0; "12a", 1/1; "4sb", 0/1; "1", 0/0; "12p", 0/1)
9. Lymphatic invasion : present (+++)
10. Venous invasion : not identified
11. Perineural invasion : present
12. Peritoneal cytology : negative
13. AJCC stage by 7th edition: pT3 N3a

À§¾Ï ÀǽÉÀ̳ª ù Á¶Á÷°Ë»ç¿¡¼­ ¾ÏÀ¸·Î ³ª¿ÀÁö ¾Ê¾Ò´Ù´Â ¼Ò°ßÀ¸·Î ÀǷڵǼ̽À´Ï´Ù. ¿ÜºÎ ½½¶óÀ̵å ÀçÆǵ¶ °á°ú chronic gastritis with lymphoepithelial lesion-like change·Î º¸°íµÇ¾ú½À´Ï´Ù. Áï½Ã ³»½Ã°æ Á¶Á÷°Ë»ç Àç°ËÀ» ÇÏ¿´°í mucin pool with some atypical cells, suspected mucin-producing adenocarcinoma·Î º¸°íµÇ¾î ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù. ¸Å¿ì ½ÉÇß½À´Ï´Ù.
Stomach, total gastrectomy:
. Advanced gastric carcinoma
1. Location : upper third, Center at body and lesser curvature
2. Gross type : Borrmann type 4
3. Histologic type : mucinous adenocarcinoma
4. Histologic type by Lauren : diffuse
5. Size : 12.5x7 cm
6. Depth of invasion : invades serosa (pT4a)
7. Resection margin: free from carcinoma, safety margin: proximal 3cm, distal 15cm
8. Lymphatic invasion : present
9. Venous invasion : present (extramural)
10. Perineural invasion : present
11. Lymph node metastasis : metastasis to 23 out of 59 regional lymph nodes (pN3b) (perinodal extension: present) (23/59: "1", 1/9; "3", 14/18; "4", 0/2; "4sb", 0/1; "5", 0/0; "6", 0/5; "7", 3/12; "8a", 3/8; "9", 0/0; "11p", 2/3; "12a", 0/1; "2", 0/0; "10", 0/0)
12. Peritoneal cytology : negative
13. AJCC stage by 7th edition: pT4a N3b


Stomach, radical subtotal gastrectomy: Early gastric carcinoma
1. Location : middle third, Center at angle and lesser curvature
2. Gross type : EGC type IIa+IIb
3. Histologic type : mucinous adenocarcinoma (mucinous carcinoma portion: 90%)
4. Histologic type by Lauren : mixed
5. Size : 3.0x2.5 cm
6. Depth of invasion : invades submucosa (sm3) (pT1b)
7. Resection margin: free from carcinoma, safety margin: proximal 3.8 cm, distal 3.7 cm
8. Lymph node metastasis : no metastasis in 42 regional lymph nodes (pN0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. AJCC stage by 8th edition: pT1a N0


[FAQ]

[2014-3-31. ¾Öµ¶ÀÚ Áõ·Ê (Mº´¿ø M¼±»ý´Ô)]

Àúµµ ÃÖ±Ù ¾î·Á¿î mucinous adenocarcinoma Áõ·Ê¸¦ °æÇèÇÏ¿´½À´Ï´Ù. Àú´Â ÃÖ±Ù¿¡ Å©±â°¡ ¾Ö¸ÅÇÑ SMT(1.5-2 cm)ÀÇ Áø´ÜÀ» À§ÇÏ¿© precut & biopsy¸¦ ÇÏ´Â ¿¬±¸¸¦ ÁøÇàÁßÀÔ´Ï´Ù. FNAÇϱ⠾î·Á¿î °æ¿ìÀÔ´Ï´Ù. EUS´Â ºñ½Ñ °Ë»çÀÓ¿¡µµ Á¤È®ÇÑ Á¶Á÷Áø´ÜÀÌ ¾ÈµÇ´Ï È­³»´Â ȯÀÚ°¡ Àֱ⵵ Çϱ¸¿ä...

70´ë ¿©ÀÚ È¯ÀÚ¿´½À´Ï´Ù. ³»½Ã°æ¿¡¼­´Â ÀüÇüÀûÀÎ SMT¿´½À´Ï´Ù. À§Ä¡´Â ÀüÁ¤ºÎ ¼Ò¸¸, Å©±â´Â 1.5 cm Á¤µµ¿´°í, EUS¿¡¼­ heterogenous mixed echoic mass¿´½À´Ï´Ù. ±×·¡¼­ Dual knife·Î precutÀ» »ì¦ÇÏ°í Á¶Á÷°Ë»ç¸¦ ÇÏ¿´½À´Ï´Ù. ±×·¨´õ´Ï Á©¶óƾ °°Àº ¹°ÁúÀÌ ³ª¿Ô½À´Ï´Ù. Á¶Á÷°Ë»ç °á°ú´Â ´ÙÀ½°ú °°¾Ò½À´Ï´Ù.

Stomach, antrum, endoscopic biopsy; Tiny pieces of fibrovascular tissue with mucinous material (See note)
(Note) No epithelial component is present in mucin. Differential diagnosis includes mucin containing benign lesions and mucinous adenocarcinoma. Further evaluation is recommended.

°í¹ÎÇÏ´Ù°¡ ESD¸¦ ÇÏÀÚ°í Çß½À´Ï´Ù. Á¶Á÷°Ë»ç¸¦ ´Ù½Ã Çصµ °á°ú°¡ ´Þ¶óÁöÁö ¾ÊÀ» °Í °°¾Æ ¾Æ¿¹ ESD¸¦ ÇÏÀÚ°í Çß½À´Ï´Ù. ÃÊÀ½ÆĻ󿡼­ 3¹ø° Ãþ¿¡ ±¹ÇѵǾú´Ù´Â °ÍÀ» ¾Ë¾Ò±â ¶§¹®¿¡ Á¤È®ÇÑ Áø´ÜÀ» À§ÇØ ±ÇÇß½À´Ï´Ù. Á¶Á÷°Ë»ç´Â ÷´Ü¿¡¼­ Ç߱⠶§¹®¿¡ ½Ã¼ú¿¡´Â ¿µÇâÀÌ ¾ø¾ú½À´Ï´Ù. ´ÙÀ½°ú °°Àº °á°ú°¡ ³ª¿Ô½À´Ï´Ù.

Stomach, endoscopic submucosal dissection; MUCINOUS ADENOCARCINOMA with signet ring cell feature
1) Location of tumor: lesser curvature of antrum
2) Tumor size: 1.8x1.4x0.4 cm
3) Depth of invasion: submucosa (sm3)
4) Surgical margins: involved by carcinoma at deep resection margin, and involved by mucin pool at lateral resection margin
5) Lymphatic invasion: not identified
6) Venous invasion: not identified
7) Perineural invasion: not identified
8) Preexisting adenoma: not identified
Note) Epicenter of tumor is submucosa. A part of tumor extends to mucosa. Definite cancer cells are not identified in foveolar epithelium. Differential diagnosis includes gastric adenocarcinoma and metastatic adenocarcinoma. Further evaluation is recommended.

°á±¹ ¼ö¼úÀ» Çß°í, ÀÓÆļ± ÀüÀ̳ª À§¿¡ ³²¾ÆÀÖ´Â Á¶Á÷Àº ¾ø¾ú½À´Ï´Ù.


[2014-3-31. ÀÌÁØÇà ÀÇ°ß]

³»½Ã°æÀº Çϸé ÇÒ¼ö·Ï ¾î·Á¿öÁý´Ï´Ù. ±×³É Æò¹üÇÑ SMT Áß¿¡ mucinous adenocarcinoma°¡ ¼û¾îÀÖ´Ù´Â °ÍÀ» »ý°¢ÇÏ¸é ¿À½ÏÇÕ´Ï´Ù. ±×·¸´Ù°í ¸ðµç °æ¿ì ESD¿Í °°Àº Àû±ØÀûÀÎ ¹æ¹ýÀ» ÃëÇÒ ¼öµµ ¾ø°í... ¶Õ¾îÁö°Ô »ìÆ캸°í ÀûÀýÈ÷ ÃßÀû°üÂûÇÒ ¼ö ¹Û¿¡ ¾øÀ» °Í °°½À´Ï´Ù. ÀûÀýÈ÷ ÃßÀû°üÂûÀ» Çϸé Å« ¹®Á¦°¡ ³ª±â Àü¿¡ Áø´ÜµÇ´Â ¿¹°¡ ¸¹À» °ÍÀ¸·Î ¹Ï½À´Ï´Ù.

À§Àå°ü Áø´Ü EUS¿¡ ´ëÇؼ­´Â Àú´Â º°·Î ÁÁÀº °æÇèÀÌ ¾ø½À´Ï´Ù. °¡°ÝÀº µÑ° ¹®Á¦·Î Ä¡´õ¶óµµ, °³ÀÎÀûÀ¸·Î µµ¿ò¹ÞÀº ÀûÀÌ º°·Î ¾ø½À´Ï´Ù. Çò°¥¸° °æ¿ì¸¸ ¸¹¾ÒÁö¿ä. Å©°Ô ¼ÕÇغ» ȯÀÚ À̾߱⵵ Á¾Á¾ µè½À´Ï´Ù. ±×·¡¼­ Àú´Â °ÅÀÇ Ã³¹æÇÏÁö ¾Ê½À´Ï´Ù. ÇÑ´Þ¿¡ 1-2°³ Á¤µµ ó¹æÇÕ´Ï´Ù. ÁÁÀº Áõ·Ê °¨»çÇÕ´Ï´Ù.


[References]

1) Choi JS et al. Mucinous Gastric Carcinomas Cancer 2009. PDF. ¼­¿ï´ëÇб³ º´¸®Çб³½Ç ³í¹®

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.